Cargando…

Gene Expression Profiling Predicts Sensitivity of Chronic Lymphocytic Leukemia Cells to Dasatinib

Detalles Bibliográficos
Autores principales:	Blätte, Tamara J., Machnicki, Marcin M., Glodkowska-Mrowka, Eliza, Dolnik, Anna, Karp, Marta, Karczmarczyk, Agnieszka, Giannopoulos, Krzysztof, Bullinger, Lars, Stoklosa, Tomasz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746204/ https://www.ncbi.nlm.nih.gov/pubmed/33354656 http://dx.doi.org/10.1097/HS9.0000000000000514

Ejemplares similares

In vivo, ex vivo and in vitro dasatinib activity in chronic lymphocytic leukemia
por: Giannopoulos, Krzysztof, et al.
Publicado: (2021)

Analysis of NPM1 splice variants reveals differential expression patterns of prognostic value in acute myeloid leukemia
por: Zajac, Malgorzata, et al.
Publicado: (2017)

PPARγ ligands increase antileukemic activity of second- and third-generation tyrosine kinase inhibitors in chronic myeloid leukemia cells
por: Glodkowska-Mrowka, E, et al.
Publicado: (2016)

Monoubiquitinated Fanconi Anemia D2 (FANCD2-Ub) Is Required for BCR-ABL1 Kinase -Induced Leukemogenesis
por: Koptyra, Mateusz, et al.
Publicado: (2011)

Aberrant Expression of TLR2, TLR7, TLR9, Splicing Variants of TLR4 and MYD88 in Chronic Lymphocytic Leukemia Patients
por: Skorka, Katarzyna, et al.
Publicado: (2021)

The PERK-eIF2α phosphorylation arm is a pro-survival pathway of BCR-ABL signaling and confers resistance to imatinib treatment in chronic myeloid leukemia cells
por: Kusio-Kobialka, Monika, et al.
Publicado: (2012)

Clonal Evolution of Multiple Myeloma—Clinical and Diagnostic Implications
por: Salomon-Perzyński, Aleksander, et al.
Publicado: (2021)

P393: GENETIC CHARACTERISTICS OF PEDIATRIC B-OTHER ACUTE LYMPHOBLASTIC LEUKEMIA COHORT USING TARGETED RNA SEQUENCING
por: Głodkowska-Mrówka, Eliza, et al.
Publicado: (2023)

Dynamic Changes in the Ability to Release Neutrophil ExtraCellular Traps in the Course of Childhood Acute Leukemias
por: Ostafin, Magdalena, et al.
Publicado: (2021)

P656: NOVEL THIAZOLIDINEDIONE WITH HDAC INHIBITING PROPERTIES OPTIMIZED FOR CHRONIC MYELOID LEUKEMIA TREATMENT
por: Rams, Anna, et al.
Publicado: (2023)

The Predominant Prognostic Significance of NOTCH1 Mutation Defined by Emulsion PCR in Chronic Lymphocytic Leukemia
por: Skórka, Katarzyna, et al.
Publicado: (2021)

getITD for FLT3-ITD-based MRD monitoring in AML
por: Blätte, Tamara J., et al.
Publicado: (2019)

Differential Regulation of Telomeric Complex by BCR-ABL1 Kinase in Human Cellular Models of Chronic Myeloid Leukemia—From Single Cell Analysis to Next-Generation Sequencing
por: Deregowska, Anna, et al.
Publicado: (2020)

Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
por: Hirsch, Susanne, et al.
Publicado: (2017)

The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases
por: Tabarkiewicz, Jacek, et al.
Publicado: (2015)

FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy
por: Stelmaszczyk-Emmel, Anna, et al.
Publicado: (2015)

PB1710: AN EXTENDED FLOW CYTOMETRY PANEL AS A SCREENING TOOL FOR PH-LIKE ALL
por: Cieloch, Adrianna, et al.
Publicado: (2023)

PB2062: PAROXYSMAL NOCTURNAL HEMOGLOBINURIA SCREENING AFTER INTRODUCTION OF HIGH-SENSITIVITY DIAGNOSTICS – A SINGLE-CENTER 10-YEAR EXPERIENCE
por: Głodkowska-Mrówka, Eliza, et al.
Publicado: (2023)

Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming
por: Marignac, Veronica Martinez, et al.
Publicado: (2013)

Pharmacokinetics of dasatinib for Philadelphia-positive acute lymphocytic leukemia with acquired T315I mutation
por: Takahashi, Naoto, et al.
Publicado: (2012)

Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription
por: Edelmann, Jennifer, et al.
Publicado: (2020)

The role of NPM1 alternative splicing in patients with chronic lymphocytic leukemia
por: Szelest, Monika, et al.
Publicado: (2022)

PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity
por: Koller, Paul, et al.
Publicado: (2023)

The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia
por: Deręgowska, Anna, et al.
Publicado: (2023)

Dasatinib in chronic myeloid leukemia: a review
por: Aguilera, Dolly G, et al.
Publicado: (2009)

Systematic review of dasatinib in chronic myeloid leukemia
por: Breccia, Massimo, et al.
Publicado: (2013)

The role of dasatinib in the management of chronic myeloid leukemia
por: Chen, Runzhe, et al.
Publicado: (2015)

Skin lesions in chronic myeloid leukemia patients during dasatinib treatment
por: Tarantini, Francesco, et al.
Publicado: (2019)

Co-occurrence of unclassified myeloproliferative neoplasm and giant cell arteritis in a patient treated with allogeneic hematopoietic stem cell transplantation: a case report and literature review
por: Bogucka-Fedorczuk, Aleksandra, et al.
Publicado: (2021)

Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients
por: Lauber, Chris, et al.
Publicado: (2020)

Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
por: Cocciardi, Sibylle, et al.
Publicado: (2019)

Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro
por: Amrein, Lilian, et al.
Publicado: (2009)

Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients
por: Colom-Fernández, Beatriz, et al.
Publicado: (2019)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
por: Ramchandren, Radhakrishnan, et al.
Publicado: (2009)

Efficacy of dasatinib for the treatment of intractable chronic myeloid leukemia
por: Lima, Lisa M, et al.
Publicado: (2010)

Dasatinib dose management for the treatment of chronic myeloid leukemia
por: Talpaz, Moshe, et al.
Publicado: (2018)

Expanding dasatinib beyond KIT in acute myeloid leukemia
por: Welch, John S.
Publicado: (2020)

Accumulation of CD5(+)CD19(+) B lymphocytes expressing PD-1 and PD-1L in hypertrophied pharyngeal tonsils
por: Wlasiuk, Paulina, et al.
Publicado: (2015)

Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations—NOTCH1, SF3B1, MYD88, BIRC3
por: Putowski, Maciej, et al.
Publicado: (2021)

Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
por: Ettrich, T. J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7usbkiljquotepuvklortmt30m